logo

Vital Therapies, Inc (VTL)



Trade VTL now with
  Date
  Headline
9/12/2018 5:01:11 AM Vital Therapies Says VTL-308 Study Failed To Meet Primary Endpoint Of Significant Improvement In Overall Survival
3/13/2018 4:03:23 PM Vital Therapies Q4 Loss/share $0.35 Vs. Loss $0.37 Year Ago
9/6/2017 8:05:35 AM Vital Therapies Appoints Former Receptos President And CEO Faheem Hasnain As Chairman